-The Hindu Business Line In Sirsa, Haryana’s westernmost district, the fight to end female foeticide includes tip-offs, thrilling chases and decoys “Chhori hai ! Kal marna tha , aaj mar gayi” (It’s a girl! She’ll have to die tomorrow, she died today). Deputy civil surgeon Viresh Bhushan’s face twists into a grimace as he recalls the incident at Sirsa’s Civil Hospital four years ago. A grandmother in her fifties had strangled to...

-AP New Delhi: Doctors Without Borders has challenged Pfizer’s application for an Indian patent for its pneumonia vaccine so cheaper versions can be available to children in poor countries and to humanitarian organisations. The medical aid group, also known as Medicins Sans Frontieres, said in a statement late on Friday that it was challenging Pfizer’s patent application to allow Indian manufacturers to make affordable versions of the pneumococcal conjugate vaccine. If Pfizer is...

-The Times of India NEW DELHI: Launching the 'Housing for All' scheme last June, Prime Minister Narendra Modi had said a house is a "turning point" in the lives of the poor, which leads towards a better life. Now a government study on the benefits of houses for the poor in villages reveals how a pucca (concrete) house elevates status of the family and even plays a key role in marriages. The...

-The Hindu The restrictions on private vehicle usage may have got most of the media coverage, but are by no means the only steps the government has announced. Nationally, over 35 per cent of urban households own a motorised two-wheeler and just under 10 per cent own a car, jeep or van. In Delhi, where per capita incomes are among the highest in the country, these proportions are much higher: nearly 40...

-The Times of India NEW DELHI: In a move that comes as a huge relief to patients of chronic Hepatitis C, the apex committee of the Central Drugs Standard Control Organisation (CDSCO) has granted a waiver of local trials for crucial new direct-acting antiviral drugs treating the disease. The waiver for sofosbuvir and ledipasvir co-formulation and for daclatasvir is expected to bring the generic version of these drugs, which cost a fraction...